Agile Therapeutics Statistics
Total Valuation
AGRX has a market cap or net worth of $2.74 million. The enterprise value is $2.36 million.
| Market Cap | 2.74M |
| Enterprise Value | 2.36M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AGRX has 6.86 million shares outstanding. The number of shares has increased by 359,283.18% in one year.
| Shares Outstanding | 6.86M |
| Shares Change (YoY) | +359,283.18% |
| Shares Change (QoQ) | +100,358.32% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 3.71% |
| Float | 6.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.96 |
| PS Ratio | 0.14 |
| Forward PS | 0.11 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.46
| Current Ratio | 0.46 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -123.73% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1.03M |
| Profits Per Employee | -$667,789 |
| Employee Count | 19 |
| Asset Turnover | 1.68 |
| Inventory Turnover | 4.41 |
Taxes
| Income Tax | -1.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.94% in the last 52 weeks. The beta is 1.40, so AGRX's price volatility has been higher than the market average.
| Beta (1Y) | 1.40 |
| 52-Week Price Change | -93.94% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 1.68 |
| Relative Strength Index (RSI) | 43.85 |
| Average Volume (30 Days) | 731,859 |
Short Selling Information
The latest short interest is 222,097, so 3.24% of the outstanding shares have been sold short.
| Short Interest | 222,097 |
| Short Previous Month | 213,078 |
| Short % of Shares Out | 3.24% |
| Short % of Float | 3.24% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, AGRX had revenue of $19.59 million and -$12.69 million in losses. Loss per share was -$6.38.
| Revenue | 19.59M |
| Gross Profit | 10.61M |
| Operating Income | -19.89M |
| Pretax Income | -14.47M |
| Net Income | -12.69M |
| EBITDA | -19.63M |
| EBIT | -20.01M |
| Loss Per Share | -$6.38 |
Balance Sheet
The company has $2.56 million in cash and $2.17 million in debt, giving a net cash position of $385,000 or $0.06 per share.
| Cash & Cash Equivalents | 2.56M |
| Total Debt | 2.17M |
| Net Cash | 385,000 |
| Net Cash Per Share | $0.06 |
| Equity / Book Value | -16.32M |
| Book Value Per Share | -2.38 |
| Working Capital | -11.25M |
Cash Flow
| Operating Cash Flow | -9.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.58M |
| FCF Per Share | -$0.00 |
Margins
Gross margin is 54.18%, with operating and profit margins of -101.50% and -64.76%.
| Gross Margin | 54.18% |
| Operating Margin | -101.50% |
| Pretax Margin | -73.85% |
| Profit Margin | -64.76% |
| EBITDA Margin | -100.17% |
| EBIT Margin | -102.14% |
| FCF Margin | -48.88% |
Dividends & Yields
AGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -359,283.18% |
| Shareholder Yield | -359,283.18% |
| Earnings Yield | -462.64% |
| FCF Yield | -349.21% |
Analyst Forecast
The average price target for AGRX is $12.00, which is 2,900.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 2,900.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 52.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 11, 2023. It was a reverse split with a ratio of 1:50.
| Last Split Date | Apr 11, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AGRX has an Altman Z-Score of -63.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -63.55 |
| Piotroski F-Score | 4 |